Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.
about
Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic ApproachesInterplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling.Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.Toll-like receptor 2 induces adenosine receptor A2a and promotes human squamous carcinoma cell growth via extracellular signal regulated kinases ½.
P2860
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.
@ast
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.
@en
type
label
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.
@ast
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.
@en
prefLabel
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.
@ast
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma
@en
P2093
Arash Shahangian
John B Sunwoo
June Ho Shin
Lovisa Farnebo
Yunqin Lee
P2860
P304
P356
10.18632/ONCOTARGET.3393
P407
P577
2015-04-01T00:00:00Z